Development and Validation of a Nomogram based on cell growth-related Biomarkers for Oral Squamous Cell Carcinoma
Yanjie Shuai, Yuansheng Duan, Mengqian Zhou, Kai Yue, Dandan Liu, Yan Fang, Yuxuan Wang, Yansheng Wu, Ze Zhang, Xudong Wang · Journal of Cancer · 2021
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Journal of Cancer · Ivyspring International Publisher · article · 2021
Abstract
Purpose: We aimed to develop a prognostic nomogram based on immunohistochemistry (IHC) biomarkers of patients with oral squamous cell carcinoma (OSCC).Methods: A total of 294 patients were enrolled in the study.The least absolute shrinkage and selection operator (LASSO) Cox regression model was performed to develop a combined IHC score (IHCs) classifier.Results: Five biomarkers, specifically c-Met, Vimentin, HIF-2α, VEGF-c, and Bcl-2 were extracted.Then, an IHCs classifier was developed, and patients were stratified into high-and low-IHCs groups.In the training cohort, the 5-year overall survival (OS) was 62.1% in low-IHCs group and 28.2% in high-IHCs group (P<0.001).The 5-year OS was 68.6% for the low-IHCs group and 28.4% for the high-IHCs group in the validation cohort (P<0.001).The area under the ROC curve (AUROC) of the combination of the IHCs classifier and TNM stage was 0.746 (95% CI: 0.658-0.833) in the training cohort and 0.735 (95% CI: 0.651-0.818) in the validation cohort, respectively.Conclusions: The nomogram could effectively predict the prognosis for patients with OSCC and may be employed as a potential tool to guide the individual decision-making process.
Open the resolved locator · 10.7150/jca.54475
Metadata licence: OpenAlex metadata (CC0)